These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
976 related articles for article (PubMed ID: 33323343)
1. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children. Rekhtman S; Tannenbaum R; Strunk A; Birabaharan M; Wright S; Garg A J Am Acad Dermatol; 2021 Feb; 84(2):408-414. PubMed ID: 33323343 [TBL] [Abstract][Full Text] [Related]
2. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic. Young TK; Shaw KS; Shah JK; Noor A; Alperin RA; Ratner AJ; Orlow SJ; Betensky RA; Shust GF; Kahn PJ; Oza VS JAMA Dermatol; 2021 Feb; 157(2):207-212. PubMed ID: 33295957 [TBL] [Abstract][Full Text] [Related]
3. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R; Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303 [TBL] [Abstract][Full Text] [Related]
4. Mucocutaneous manifestations in children hospitalized with COVID-19. Andina-Martinez D; Nieto-Moro M; Alonso-Cadenas JA; Añon-Hidalgo J; Hernandez-Martin A; Perez-Suarez E; Colmenero-Blanco I; Iglesias-Bouza MI; Cano-Fernandez J; Mateos-Mayo A; Torrelo A J Am Acad Dermatol; 2021 Jul; 85(1):88-94. PubMed ID: 33819537 [TBL] [Abstract][Full Text] [Related]
5. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings. Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530 [TBL] [Abstract][Full Text] [Related]
6. Severity of multisystem inflammatory syndrome in children (MIS-C) in patients with and without mucocutaneous findings. Rao M; Bond C; Haggstrom A; Bhumbra S Pediatr Dermatol; 2023 Mar; 40(2):294-300. PubMed ID: 36627110 [TBL] [Abstract][Full Text] [Related]
7. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Abrams JY; Oster ME; Godfred-Cato SE; Bryant B; Datta SD; Campbell AP; Leung JW; Tsang CA; Pierce TJ; Kennedy JL; Hammett TA; Belay ED Lancet Child Adolesc Health; 2021 May; 5(5):323-331. PubMed ID: 33711293 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG; JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505 [TBL] [Abstract][Full Text] [Related]
9. New dermatological findings of MIS-C: Can mucocutaneous involvement be associated with Severe Disease Course? Akçay N; Topkarcı Z; Menentoğlu ME; Oğur M; Sofuoğlu Aİ; Boydağ Güvenç K; Baydemir C; Şevketoğlu E Australas J Dermatol; 2022 May; 63(2):228-234. PubMed ID: 35290661 [TBL] [Abstract][Full Text] [Related]
10. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran. Mamishi S; Movahedi Z; Mohammadi M; Ziaee V; Khodabandeh M; Abdolsalehi MR; Navaeian A; Heydari H; Mahmoudi S; Pourakbari B Epidemiol Infect; 2020 Aug; 148():e196. PubMed ID: 32854812 [TBL] [Abstract][Full Text] [Related]
11. Mucocutaneous Findings of Multisystem Inflammatory Syndrome in Children: A Single-Center Experience. Böncüoğlu E; Kıymet E; Şahinkaya Ş; Cem E; Yılmaz Çelebi M; Düzgöl M; Besin D; Arıkan KÖ; Akaslan Kara A; Bayram N; Devrim İ J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 34392371 [TBL] [Abstract][Full Text] [Related]
12. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic. Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588 [TBL] [Abstract][Full Text] [Related]
13. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033 [TBL] [Abstract][Full Text] [Related]
14. Multisystem Inflammatory Syndrome in Children in New York State. Dufort EM; Koumans EH; Chow EJ; Rosenthal EM; Muse A; Rowlands J; Barranco MA; Maxted AM; Rosenberg ES; Easton D; Udo T; Kumar J; Pulver W; Smith L; Hutton B; Blog D; Zucker H; N Engl J Med; 2020 Jul; 383(4):347-358. PubMed ID: 32598830 [TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome. Keshavarz P; Yazdanpanah F; Azhdari S; Kavandi H; Nikeghbal P; Bazyar A; Rafiee F; Nejati SF; Sadabad FE; Rezaei N J Med Virol; 2021 Sep; 93(9):5458-5473. PubMed ID: 33969513 [TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations and outcomes associated with PICU admission in children with multisystem inflammatory syndrome in Taiwan: A retrospective cohort study. Tseng CT; Lin JJ; Huang JL; Chiu CH; Wu CY Int J Rheum Dis; 2024 Jan; 27(1):e14970. PubMed ID: 37947261 [TBL] [Abstract][Full Text] [Related]
17. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature. Caro-Patón GL; de Azagra-Garde AM; García-Salido A; Cabrero-Hernández M; Tamariz A; Nieto-Moro M J Intensive Care Med; 2021 Apr; 36(4):392-403. PubMed ID: 33148089 [TBL] [Abstract][Full Text] [Related]
18. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children. Brumfiel CM; DiLorenzo AM; Petronic-Rosic VM Clin Dermatol; 2021; 39(2):329-333. PubMed ID: 34272031 [TBL] [Abstract][Full Text] [Related]
19. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center. Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352 [TBL] [Abstract][Full Text] [Related]
20. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey. Tolunay O; Çelik Ü; Arslan İ; Orgun A; Demir H; Demir O; Dağdelen EÇ J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]